Galderma Group AG Stock

Equities

GALD

CH1335392721

Personal Products

Market Closed - Swiss Exchange 11:30:31 2024-05-16 am EDT 5-day change 1st Jan Change
74.83 CHF +2.51% Intraday chart for Galderma Group AG +5.26% 0.00%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2024 * 4.43B 4.02B Sales 2025 * 4.96B 4.5B Capitalization 19.67B 17.84B
Net income 2024 * 218M 198M Net income 2025 * 468M 424M EV / Sales 2024 * 4.96 x
Net Debt 2024 * 2.31B 2.09B Net Debt 2025 * 1.81B 1.64B EV / Sales 2025 * 4.33 x
P/E ratio 2024 *
93.9 x
P/E ratio 2025 *
39.9 x
Employees -
Yield 2024 *
0.07%
Yield 2025 *
0.33%
Free-Float 0%
More Fundamentals * Assessed data
Dynamic Chart
1 day+2.51%
1 week+5.26%
Current month+9.24%
1 month+19.14%
More quotes
1 week
69.06
Extreme 69.06
76.20
1 month
62.55
Extreme 62.55
76.20
Current year
60.00
Extreme 60
76.20
1 year
60.00
Extreme 60
76.20
3 years
60.00
Extreme 60
76.20
5 years
60.00
Extreme 60
76.20
10 years
60.00
Extreme 60
76.20
More quotes
Date Price Change Volume
24-05-16 74.83 +2.51% 304,091
24-05-15 73 +2.33% 205,630
24-05-14 71.34 +1.91% 285,431
24-05-13 70 -0.21% 134,250
24-05-10 70.15 -1.32% 264,466

Delayed Quote Swiss Exchange, May 16, 2024 at 11:30 am EDT

More quotes
Galderma Group AG is a Switzerland based holding Company, specializing in dermatological treatments and skin care products. The Company, throw its subsidiaries, operates a portfolio of carious self-care brands focusing primarily on dermatological solutions, through its subsidiaries. production within the portfolio include neuromodulators, fillers. and biostimulators. these products are designed to relax winkles via injection, fill wrinkles in a specific location via injection and stimulate the body's cells to function optimally. The production process, for the various products primarily takes place in house, form research and development to manufacturing. In addition, including education, scientific engagements, and other services are offered.
Calendar
More about the company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
82.7 USD
Average target price
84.63 USD
Spread / Average Target
+2.33%
Consensus

Annual profits - Rate of surprise

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW